Comparison of intermediate-dose purified urinary follicle-stimulating hormone with and without human chorionic gonadotropin for ovulation induction in polycystic ovarian disease**Supported in part by a grant from Serono Pharmaceutical Company, Randolph, Massachusetts.
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 46 (3), 518-521
- https://doi.org/10.1016/s0015-0282(16)49597-x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Purified Human Follicle-Stimulating Hormone for Ovulation Induction: A Critical ReviewSeminars in Reproductive Medicine, 1986
- CONCEPTION RATE AFTER GONADOTROPIN THERAPY IN HYPERPROLACTINEMIA AND NORMOPROLACTINEMIA1985
- Toward Understanding the Pathophysiology and Treatment of Polycystic Ovary DiseaseSeminars in Reproductive Medicine, 1984
- Follicle-Stimulating Hormone Induced Ovarian Hyperstimulation in Monkeys: Blockade of the Luteinizing Hormone Surge*Journal of Clinical Endocrinology & Metabolism, 1983
- The role of ultrasound in ovulation induction: a critical appraisalFertility and Sterility, 1981
- Spontaneous pregnancy following gonadotropin-induced ovulation and conceptionAmerican Journal of Obstetrics and Gynecology, 1972